The federal Block Grant award of $35,869,401.00 was provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Block Grants for Prevention and Treatment of Substance Abuse (CFDA 93.959) program. The award will fund a range of substance abuse prevention, treatment, and recovery services in Arizona from October 1, 2024 through September 30, 2026. Key products and services to be delivered through this funding include outpatient counseling, crisis intervention,...
The federal grant award of $31,799,748.00 was provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Block Grants for Community Mental Health Services program (CFDA 93.958). The funding supports the Arizona Health Care Cost Containment System (AHCCCS), Arizona's state Medicaid agency, in delivering comprehensive behavioral health services to adults with serious mental illness and children with serious emotional disturbances across the state. The block...
The federal Block Grant award with ID B09SM089814 was provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Block Grants for Community Mental Health Services program (CFDA 93.958). The $887,145.00 grant will be used by the Arizona Health Care Cost Containment System (AHCCCS), Arizona's state Medicaid agency, to deliver a range of comprehensive community mental health services to adults with serious mental illness and children with serious emotional...
The federal Block Grant award of $837,388,144.00 was provided by the Centers for Medicaid and CHIP Services (CMCS), a division of the U.S. Department of Health and Human Services, under the Grants to States for Medicaid program (CFDA 93.778). This funding supports the Arizona Health Care Cost Containment System (AHCCCS), Arizona's state Medicaid agency, in delivering comprehensive healthcare services for low-income populations in Arizona, including medical, behavioral health, and substance abuse...
The Tohono O'Odham Nation was awarded a $1,005,154 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program by the Department of Health and Human Services Substance Abuse and Mental Health Services Administration (SAMHSA). The grant, awarded on September 30, 2024, will fund the Tohono O'Odham Nation Opioid Response Project to serve the Tohono O'Odham Nation, a federally recognized tribe with 36,000 members in southern...
This Project Grant award, valued at $1,773,802.00, was provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The grant aims to address opioid use disorder and substance abuse within the Gila River Indian Community (GRIC) in Arizona. The key products and services to be delivered under this 5-year project include: (1) enhancing community partner...
The federal Project Grant award H79TI087171, funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program, aims to connect existing prenatal, labor and delivery, postpartum, pediatric, and substance use disorder treatment providers to increase patient engagement, integrated whole-person care, and wraparound services for pregnant and postpartum women with...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $999,996 Project Grant (CFDA 93.243) to the Hualapai Tribal Council in Arizona. The grant will fund a 5-year program to provide opioid use prevention and response services to the Hualapai tribal community. The program aims to educate the community on the dangers of opioid use, provide Naloxone training, and connect individuals and families to available resources for opioid abuse. This grant builds upon the tribe's...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $487,461 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to Native Health, a non-profit minority-owned healthcare organization in Phoenix, Arizona. The grant funding will support an Integrated Health and Outreach Program for HIV and SUD Prevention targeting underserved urban Indigenous, Hispanic, and minority populations in...
This federal Block Grant award of $313,159,856.00 was provided by the Center for Medicaid and Chip Services, a division of the U.S. Department of Health and Human Services, under the Children's Health Insurance Program (CFDA 93.767). The grant supports the Arizona Health Care Cost Containment System (AHCCCS), Arizona's state Medicaid agency, in maintaining and expanding healthcare coverage and services for uninsured, low-income children and, at the state's option, low-income pregnant women....
The Arizona Health Care Cost Containment System (AHCCCS) was awarded a $104,400,264 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program administered by the Substance Abuse and Mental Health Services Administration (SAMHSA). The grant, titled the "Arizona State Opioid Response Grant IV (FY 2024)", aims to reduce the prevalence of opioid and stimulant-related overdose and mortality across Arizona.
The key products and services to be delivered through this grant include: 1) Increasing access to FDA-approved medications for the treatment of opioid use disorder (MOUD); 2) Implementing and supporting a continuum of evidence-based prevention, treatment, and recovery support services for opioid use disorder, stimulant use disorder, and concurrent substance use/mental health disorders. The target populations include individuals actively using opioids and stimulants, transition-aged youth, individuals at risk for overdose or misuse, those in recovery, and various other high-risk groups. Over the 3-year project period from Sep 2024 to Sep 2027, the grant aims to provide prevention programming to 6 million unduplicated individuals and reach 21,245 individuals with treatment and recovery services, with 9,500 completing the CSAT GPRA assessment tool.